What echocardiographic and clinical criteria define a hemodynamically significant patent ductus arteriosus (hsPDA) in preterm infants (≤33 weeks gestation, birth weight <1.5 kg, ≤21 days old)?

Hemodynamically Significant PDA (hsPDA) Criteria in Preterm Infants

A hemodynamically significant PDA in preterm infants ≤33 weeks gestation, birth weight <1.5 kg, and ≤21 days old is defined by echocardiographic evidence of left-to-right shunting with left atrial-to-aortic root ratio (LA/Ao) >1.4, combined with either left pulmonary artery end-diastolic velocity >0.2 m/s or retrograde diastolic flow in the descending aorta, plus clinical evidence of left ventricular volume overload.

Echocardiographic Criteria

The diagnosis requires visualization of the PDA with color Doppler demonstrating shunting across the defect 1. The following parameters define hemodynamic significance:

Primary Echocardiographic Markers:

• LA/Ao ratio >1.4 - indicates left atrial enlargement from volume overload 2, 3
• Left pulmonary artery (LPA) end-diastolic velocity >0.2 m/s - reflects diastolic steal 2, 4
• Retrograde diastolic flow in descending aorta - demonstrates systemic diastolic steal 2, 5
• PDA diameter-to-weight ratio - larger ratios at 48-72 hours predict hsPDA 3

Additional Supportive Parameters:

Recent evidence shows that dynamic blood flow assessment is more reliable than static chamber measurements 4. Specifically:

• Elevated mitral inflow E-wave velocity - indicates increased left ventricular filling from ductal shunt 4
• Increased LPA end-diastolic velocity - superior to LA/Ao ratio for predicting hsPDA 4
• Absent or reversed diastolic flow in celiac/mesenteric arteries - present in 44% of hsPDA cases, indicating compromised systemic perfusion 5, 6

The 2019 ACC/AHA guidelines classify PDA severity as "moderate to large" when likely hemodynamically significant, versus "small" when hemodynamically insignificant 7.

Clinical Criteria

While echocardiography remains definitive 1, clinical signs alone are unreliable in the first 72 hours of life 8. However, the following clinical parameters support the diagnosis:

Clinical Risk Factors:

• Lower gestational age and birth weight 3, 8
• Maternal eclampsia/preeclampsia 3
• Neonatal asphyxia 3
• Need for surfactant and mechanical ventilation within 72 hours 3
• Higher fluid intake in first 24 hours 3

Clinical Signs (Less Reliable Early):

• Continuous "machinery" murmur (best heard left infraclavicular area) 1
• Wide pulse pressure 1
• Hyperdynamic precordium 8
• Bounding pulses 1
• Worsening respiratory status 8

Important caveat: A clinical diagnostic score combining tachycardia, murmur, hyperdynamic chest, and respiratory deterioration has 84% sensitivity and 80% specificity, but should not replace echocardiography 9.

Systemic Hemodynamic Parameters

Emerging evidence demonstrates that combining echocardiography with systemic hemodynamic monitoring at 72 hours significantly improves prediction (AUC 0.981, sensitivity 100%, specificity 90%) 3:

• Increased stroke index (SI) and cardiac output index (CI) at 48-72 hours
• Elevated total body water percentage (TBW%) at 48-72 hours
• Decreased total peripheral resistance index (TPRI) at 48-72 hours

Timing of Assessment

Echocardiographic screening should occur at 48-72 hours of life 10, 11. The ACC/AHA guidelines specifically recommend follow-up assessment of neonates with PDA who have undergone medical or surgical intervention (Class I indication) 10.

Guidelines emphasize that premature infants with respiratory failure require Doppler echocardiography to assess PDA patency, direction and degree of shunting, and pulmonary artery pressure 10. The ESPNIC POCUS guidelines strongly recommend using point-of-care ultrasound to assess PDA patency in preterm infants 11.

Common Pitfalls

1. Over-reliance on LA/Ao ratio alone: Recent data shows mitral E-wave and LPA end-diastolic velocities are more reliable than LA/Ao ratio 4

2. Ignoring systemic perfusion markers: Absent or reversed diastolic flow in celiac/mesenteric arteries occurs in 44% of hsPDA but is often overlooked 5, 6

3. Premature clinical diagnosis: Clinical signs have poor predictive value before 72 hours; echocardiography is required 8

4. Missing altitude effects: While PDA prevalence is high (85% at 72 hours), hemodynamic significance occurs in only 11.7%, regardless of altitude 12

5. Assuming cerebral/renal compromise: Interestingly, cerebral and renal tissue oxygenation measured by NIRS is not affected by hsPDA or retrograde aortic flow within 2 weeks of birth 2, though mesenteric perfusion is compromised 5, 6

Diagnostic Algorithm

1. Screen at 48-72 hours with comprehensive echocardiography including:

   • Color Doppler visualization of PDA
   • LA/Ao ratio measurement
   • LPA end-diastolic velocity
   • Descending aorta diastolic flow pattern
   • Mitral E-wave velocity
   • PDA diameter indexed to weight

2. Assess systemic perfusion with Doppler of celiac/mesenteric arteries if available 5, 6

3. Consider hemodynamic monitoring (stroke index, cardiac output, peripheral resistance) at 48-72 hours for enhanced prediction 3

4. Diagnose hsPDA when LA/Ao >1.4 PLUS (LPA end-diastolic velocity >0.2 m/s OR retrograde descending aortic flow) with clinical context

The evidence strongly supports that multiparametric echocardiographic assessment at 72 hours, incorporating both structural and flow-based measurements, provides the most accurate diagnosis of hsPDA in this vulnerable population 3, 4.